chr9-91361813-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001698.3(AUH):​c.77G>A​(p.Cys26Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,513,374 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0055 ( 9 hom., cov: 33)
Exomes 𝑓: 0.00063 ( 11 hom. )

Consequence

AUH
NM_001698.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.709
Variant links:
Genes affected
AUH (HGNC:890): (AU RNA binding methylglutaconyl-CoA hydratase) This gene encodes bifunctional mitochondrial protein that has both RNA-binding and hydratase activities. The encoded protein is a methylglutaconyl-CoA hydratase that catalyzes the hydration of 3-methylglutaconyl-CoA to 3-hydroxy-3-methyl-glutaryl-CoA, a critical step in the leucine degradation pathway. This protein also binds AU-rich elements (AREs) found in the 3' UTRs of rapidly decaying mRNAs including c-fos, c-myc and granulocyte/ macrophage colony stimulating factor. ARE elements are involved in directing RNA to rapid degradation and deadenylation. This protein is localizes to the mitochondrial matrix and the inner mitochondrial membrane and may be involved in mitochondrial protein synthesis. Mutations in this gene are the cause of 3-methylglutaconic aciduria, type I. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028543174).
BP6
Variant 9-91361813-C-T is Benign according to our data. Variant chr9-91361813-C-T is described in ClinVar as [Benign]. Clinvar id is 136474.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0055 (838/152250) while in subpopulation AFR AF= 0.0191 (795/41550). AF 95% confidence interval is 0.018. There are 9 homozygotes in gnomad4. There are 382 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AUHNM_001698.3 linkuse as main transcriptc.77G>A p.Cys26Tyr missense_variant 1/10 ENST00000375731.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AUHENST00000375731.9 linkuse as main transcriptc.77G>A p.Cys26Tyr missense_variant 1/101 NM_001698.3 P1Q13825-1
AUHENST00000303617.5 linkuse as main transcriptc.77G>A p.Cys26Tyr missense_variant 1/91 Q13825-2
AUHENST00000478465.5 linkuse as main transcriptn.75G>A non_coding_transcript_exon_variant 1/63

Frequencies

GnomAD3 genomes
AF:
0.00542
AC:
825
AN:
152142
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0189
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.000870
AC:
96
AN:
110300
Hom.:
1
AF XY:
0.000713
AC XY:
44
AN XY:
61734
show subpopulations
Gnomad AFR exome
AF:
0.0308
Gnomad AMR exome
AF:
0.00111
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000104
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000118
Gnomad OTH exome
AF:
0.000637
GnomAD4 exome
AF:
0.000635
AC:
864
AN:
1361124
Hom.:
11
Cov.:
32
AF XY:
0.000572
AC XY:
384
AN XY:
671478
show subpopulations
Gnomad4 AFR exome
AF:
0.0196
Gnomad4 AMR exome
AF:
0.00145
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000658
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000165
Gnomad4 OTH exome
AF:
0.00147
GnomAD4 genome
AF:
0.00550
AC:
838
AN:
152250
Hom.:
9
Cov.:
33
AF XY:
0.00513
AC XY:
382
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.0191
Gnomad4 AMR
AF:
0.00176
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00238
Hom.:
2
Bravo
AF:
0.00620
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0119
AC:
35
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000993
AC:
91
Asia WGS
AF:
0.00116
AC:
4
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

3-methylglutaconic aciduria type 1 Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 28, 2021- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicMar 15, 2016- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJan 30, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
15
DANN
Benign
0.70
DEOGEN2
Benign
0.21
T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.64
T;T
MetaRNN
Benign
0.0029
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.11
N;N
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.090
Sift
Benign
0.38
T;T
Sift4G
Benign
0.73
T;T
Polyphen
0.0
B;B
Vest4
0.21
MVP
0.33
MPC
0.45
ClinPred
0.0016
T
GERP RS
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.090
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs74484860; hg19: chr9-94124095; API